Home

Mary Theresa Coelho

CIK 1720772 · EVP and CFO · last filed 2026-07-20

Mary Theresa Coelho is an EVP and CFO who has filed 24 SEC Form 4 insider transactions across 7 companies since 2018. The most recent filing, for NOTV, was dated Jul 20, 2026. Across all open-market trades the lifetime net is −$23.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $373.0K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$373.0K

Companies

7

Total Filings

24

Lifetime Open-Market Net

-$23.8K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Inotiv, Inc. (NOTV) Delisted Director 0 $0.08 $0 -$12.9K 5 2026-07-20
HOOKIPA Pharma Inc. (HOOK) Delisted EVP and CFO 56,266 $1.15 $64.7K -$12.5K 4 2025-07-23
GridAI Technologies Corp. (FWBI) Delisted Director 20,237 $2.96 $59.9K $0 3 2024-01-04
Gamida Cell Ltd. (GMDA) Delisted Chief Financial Officer — $0.03 — $0 1 2023-06-14
CinCor Pharma, Inc. (CINC) Delisted EVP CFO & Chief BD Officer 100 $29.06 $2.9K $1.6K 1 2022-01-13
GridAI Technologies Corp. (AZRX) Delisted Director — $3.45 — $0 1 2021-09-13
BCPC Chief Financial Officer 2,105 $177.19 $373.0K $0 2 2018-10-30

Recent Filings

24 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-20 Inotiv, Inc. (NOTV) Delisted Other (J) −74,303 $0 EDGAR
2025-07-23 HOOKIPA Pharma Inc. (HOOK) Delisted Sell (S) −13,609 -$12.5K EDGAR
2025-04-02 Inotiv, Inc. (NOTV) Delisted Sell (S) −5,500 -$12.9K EDGAR
2025-04-01 Inotiv, Inc. (NOTV) Delisted Notice (144) −5,500 -$15.6K EDGAR
2025-03-18 Inotiv, Inc. (NOTV) Delisted Grant (A) +39,392 $0 EDGAR
2024-08-14 Inotiv, Inc. (NOTV) Delisted Grant (A) +27,500 $0 EDGAR
2024-07-24 HOOKIPA Pharma Inc. (HOOK) Delisted Grant (A) +69,875 $0 EDGAR
2024-06-18 HOOKIPA Pharma Inc. (HOOK) Delisted Grant (A) — $0 EDGAR
2024-01-04 GridAI Technologies Corp. (FWBI) Delisted Grant (A) +19,633 $0 EDGAR
2023-10-18 Inotiv, Inc. (NOTV) Delisted Grant (A) +12,911 $0 EDGAR
Showing 1–10 of 24
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.